CHRS

NASDAQStock

Coherus Oncology, Inc.

$1.63-0.07 (-3.85%)

52-Week Range

$0.72

$2.51

Key Stats

Market Cap

196.4M

P/E Ratio

1.19

Dividend Yield

—

Beta

1.09

Volume

989.8K

Avg Volume

1.4M

Performance

+4.97%

+21.58%

+24.26%

YTD

+23.36%

+84.56%

-73.47%

-89.42%

Price Chart

ETF Exposure

CHRS is held by 51 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	2,421	$5K	$1.29B	0.17%

PreviousPage 2 of 2

About CHRS ETF Exposure

Coherus Oncology, Inc. (CHRS) is held by 51 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 196.4M, CHRS is a widely held institutional stock. The stock currently trades at $1.63. Investors can gain exposure to CHRS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CHRS, sorted by portfolio weight.